BioAge Labs (BIOA) Change in Acquisitions & Divestments (2025 - 2026)

BioAge Labs' (BIOA) quarterly Change in Acquisitions & Divestments came in at $33.5 million in Q1 2026, up 28.8% quarter-over-quarter from $26.0 million in Q4 2025.

BioAge Labs (BIOA) Change in Acquisitions & Divestments (2025 - 2026) Analysis & Trends

BioAge Labs has disclosed Change in Acquisitions & Divestments across 2 years of filings, most recently posting $33.5 million for Q1 2026.

  • Change in Acquisitions & Divestments for Q1 2026 came in at $33.5 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $93.7 million (changed N/A YoY), and the FY2025 annual result was $60.2 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments came in at $33.5 million for Q1 2026 at BioAge Labs, up from $26.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $33.5 million in Q1 2026 to a low of $8.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 BioAge Labs 671.19 Mn 288.00 Mn -10.37 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 33.49 Mn
Mar 31, 2026 33.49 Mn
Dec 31, 2025 26.00 Mn
Dec 31, 2025 26.00 Mn
Sep 30, 2025 25.75 Mn
Sep 30, 2025 25.75 Mn
Jun 30, 2025 8.50 Mn
Jun 30, 2025 8.50 Mn